COVID-19 vaccination, dengue hepatitis, and recurrent unilateral anterior uveitis
Indian Journal of Ophthalmology · 2023
DOI: 10.4103/ijo.ijo_2064_22 ↗Kurz gefasst
Fallbericht in der Zeitschrift Indian Journal of Ophthalmology, 2023. Verfasst von Srinivasan Sanjay und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Uveitis and Ocular immunology, Narayana Nethralaya, Bengaluru, Karnataka, India. Hauptthemen laut MEDLINE: Hepatitis A, COVID-19, Uveitis, Anterior, Hepatitis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
A 36-year-old Asian Indian male presented with redness and pain in his right eye of 1 week duration. He was diagnosed to have right acute anterior uveitis and had a history of being admitted at a local hospital for dengue hepatitis a month earlier. He had been on adalimumab 40 mg three weekly once and oral methotrexate 20 mg/week for human leucocyte antigen (HLA) B27 spondyloarthropathy and recurrent anterior uveitis. Our patient had re-activation of his anterior chamber inflammation on three distinct occasions: first, 3 weeks following recovery from coronavirus disease 2019 (COVID-19), the second after the second dose of COVID-19 vaccination, and the third after recovery from dengue fever-associated hepatitis. We propose molecular mimicry and bystander activation as the postulated mechanisms for the re-activation of his anterior uveitis. In conclusion, patients with auto-immune diseases can have recurrent ocular inflammation following COVID-19 or its vaccination or dengue fever as seen in our patient. The anterior uveitis is usually mild and responds to topical steroids. Additional immuno-suppression may not be needed. Mild ocular inflammation following vaccination should not deter individuals from getting COVID-19 vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Uveitis and Ocular immunology, Narayana Nethralaya, Bengaluru, Karnataka, India.
Zitieren
APA
Sanjay, S., Kawali, A., & Mahendradas, P. (2023). COVID-19 vaccination, dengue hepatitis, and recurrent unilateral anterior uveitis. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_2064_22
Vancouver
Sanjay S, Kawali A, Mahendradas P. COVID-19 vaccination, dengue hepatitis, and recurrent unilateral anterior uveitis. Indian Journal of Ophthalmology. 2023. doi:10.4103/ijo.ijo_2064_22
BibTeX
@article{Sanjay2023,
author = {Sanjay, Srinivasan and Kawali, Ankush and Mahendradas, Padmamalini},
title = {COVID-19 vaccination, dengue hepatitis, and recurrent unilateral anterior uveitis},
journal = {Indian Journal of Ophthalmology},
year = {2023},
doi = {10.4103/ijo.ijo_2064_22}
}
EUVIMED